![Christine Nash](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christine Nash
Direktor/Vorstandsmitglied bei
RALLYBIO CORPORATION
Vermögen: - $ am 31.07.2026
Profil
Christine A. Nash currently works at Rallybio Corp., as Independent Director from 2022.
Ms. Nash also formerly worked at CoTherix, Inc., as Marketing Director from 2006 to 2007, CM Group LLC, as Director from 2019 to 2022, Eli Lilly & Co., as Principal, Genesoft Pharmaceuticals, Inc., as Product Manager, Chatiemac Consulting LLC, as Principal, Oncology Therapeutics Network Corp., as Principal, Imana, Inc., as Principal, and Hyperion Therapeutics, Inc., as Chief Commercial Officer & Senior Vice President from 2012 to 2015.
Ms. Nash received her undergraduate degree and Masters Business Admin degree from Stanford University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RALLYBIO CORPORATION -.--% | 19.12.2025 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Christine Nash
| Unternehmen | Position | Beginn |
|---|---|---|
| RALLYBIO CORPORATION | Direktor/Vorstandsmitglied | 04.04.2022 |
Ehemalige bekannte Positionen von Christine Nash
| Unternehmen | Position | Ende |
|---|---|---|
CM Group LLC
 CM Group LLC Packaged SoftwareTechnology Services Operates as a marketing technology company | Direktor/Vorstandsmitglied | 01.09.2022 |
| HYPERION THERAPEUTICS INC | Corporate Officer/Principal | 01.05.2015 |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Vertrieb & Marketing | 01.02.2007 |
Chatiemac Consulting LLC | Corporate Officer/Principal | - |
Imana, Inc. | Corporate Officer/Principal | - |
Ausbildung von Christine Nash
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Genesoft Pharmaceuticals, Inc.
 Genesoft Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops anti-infective products | Commercial Services |
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncology Therapeutics Network Corp.
 Oncology Therapeutics Network Corp. Medical DistributorsDistribution Services Distributes pharmaceuticals to oncologists | Distribution Services |
CM Group LLC
CM Group LLC Packaged SoftwareTechnology Services Operates as a marketing technology company | Technology Services |
Imana, Inc. | |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Chatiemac Consulting LLC |
